Capital Fund Management (CFM)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-22,088
| Closed | -$4.9M | – | 2009 |
|
|
2025
Q4 | $5.05M | Sell |
22,088
-171,405
| -89% | -$39M | 0.01% | 1189 |
|
|
2025
Q3 | $44.8M | Sell |
193,493
-83,211
| -30% | -$16.9M | 0.12% | 219 |
|
|
2025
Q2 | $51.4M | Buy |
+276,704
| New | +$51.4M | 0.14% | 199 |
|
|
2024
Q1 | – | Sell |
-276,712
| Closed | -$47.7M | – | 1943 |
|
|
2023
Q4 | $42.9M | Sell |
276,712
-442,483
| -62% | -$64.5M | 0.12% | 243 |
|
|
2023
Q3 | $107M | Buy |
719,195
+385,016
| +115% | +$56.5M | 0.37% | 47 |
|
|
2023
Q2 | $45M | Buy |
+334,179
| New | +$49M | 0.18% | 144 |
|
|
2023
Q1 | – | Sell |
-128,808
| Closed | -$19.7M | – | 1528 |
|
|
2022
Q4 | $20.8M | Sell |
128,808
-19,234
| -13% | -$2.95M | 0.14% | 187 |
|
|
2022
Q3 | $19.9M | Buy |
+148,042
| New | +$21.2M | 0.16% | 164 |
|
|
2022
Q1 | – | Sell |
-87,617
| Closed | -$12.7M | – | 1416 |
|
|
2021
Q4 | $11.9M | Sell |
87,617
-71,951
| -45% | -$8.5M | 0.09% | 322 |
|
|
2021
Q3 | $17.2M | Buy |
159,568
+5,347
| +3% | +$611K | 0.13% | 210 |
|
|
2021
Q2 | $17.4M | Buy |
154,221
+64,973
| +73% | +$7.32M | 0.14% | 186 |
|
|
2021
Q1 | $9.66M | Buy |
+89,248
| New | +$9.55M | 0.11% | 238 |
|
|
2020
Q3 | – | Sell |
-45,674
| Closed | -$4.3M | – | 1170 |
|
|
2020
Q2 | $4.48M | Sell |
45,674
-432,538
| -90% | -$38.1M | 0.07% | 321 |
|
|
2020
Q1 | $36.4M | Buy |
478,212
+347,634
| +266% | +$29.6M | 0.56% | 24 |
|
|
2019
Q4 | $11.6M | Sell |
130,578
-400,618
| -75% | -$33.3M | 0.09% | 277 |
|
|
2019
Q3 | $40.2M | Sell |
531,196
-100,000
| -16% | -$6.86M | 0.36% | 54 |
|
|
2019
Q2 | $45.9M | Buy |
631,196
+66,800
| +12% | +$5.25M | 0.42% | 37 |
|
|
2019
Q1 | $45.5M | Buy |
564,396
+535,969
| +1,885% | +$43.8M | 0.41% | 38 |
|
|
2018
Q4 | $2.62M | Sell |
28,427
-1,439,785
| -98% | -$127M | 0.02% | 744 |
|
|
2018
Q3 | $139M | Buy |
1,468,212
+200,000
| +16% | +$19M | 0.76% | 3 |
|
|
2018
Q2 | $118M | Buy |
1,268,212
+873,100
| +221% | +$85.3M | 0.61% | 6 |
|
|
2018
Q1 | $37.4M | Buy |
+395,112
| New | +$43.4M | 0.22% | 114 |
|
|
2017
Q2 | – | Sell |
-55,574
| Closed | -$3.74M | – | 1420 |
|
|
2017
Q1 | $3.62M | Buy |
+55,574
| New | +$3.49M | 0.03% | 574 |
|
|
2016
Q2 | – | Sell |
-808,764
| Closed | -$49.3M | – | 1473 |
|
|
2016
Q1 | $46.2M | Buy |
+808,764
| New | +$45.1M | 0.45% | 50 |
|
|
2015
Q2 | – | Sell |
-1,454,853
| Closed | -$95M | – | 1431 |
|
|
2015
Q1 | $85.2M | Buy |
1,454,853
+1,425,407
| +4,841% | +$86.1M | 1.16% | 7 |
|
|
2014
Q4 | $1.93M | Sell |
29,446
-285,753
| -91% | -$18M | 0.02% | 693 |
|
|
2014
Q3 | $18.2M | Buy |
315,199
+165,699
| +111% | +$9.2M | 0.2% | 115 |
|
|
2014
Q2 | $8.44M | Buy |
+149,500
| New | +$7.84M | 0.09% | 281 |
|
Other funds holding ABBV
VCM
VPM
Capital Fund Management (CFM)'s ABBV Position: Q1 2026 in Review
Capital Fund Management (CFM) sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 22,088 shares — an estimated $4.9M sold.
Capital Fund Management (CFM) first reported a position in ABBV in Q2 2014 and held it in 28 quarters. The position peaked at $139M in Q3 2018. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Capital Fund Management (CFM) reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Capital Fund Management (CFM) sold 22,088 AbbVie shares in Q1 2026, an estimated $4.9M.
- Capital Fund Management (CFM) first reported a position in AbbVie in Q2 2014 and held it in 28 quarters.
- Capital Fund Management (CFM)'s AbbVie position peaked at $139M in Q3 2018.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.